Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
Recruiting · NCT06370780 · Interventional (participants receive a specific treatment) · Lead sponsor: University of California, Los Angeles
View the official record on ClinicalTrials.gov →Interventions studied
EPI LOVE
What this trial is about
Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Have access to a personal smartphone device;
- Over 18 years of age;
- Speak English or Spanish;
- Living with HIV
- Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression;
- Active substance use or mental health disorder;
- Willing and able to provide written informed consent to take part in the study.
Exclusion criteria
- Unwilling or unable to provide reliable contact information;
- Unwilling to provide blood sample for HIV virology testing;
- Living with HIV and virally suppressed and not at risk of becoming unsuppressed in the near future.
Where it is running
1 location listed across 1 US state.
- University of California, Los Angeles - Los Angeles, California, United States